Hong Kong stocks surged | Kangfang Biological (09926.HK) opened high and rose by 5%, and Anpli was approved by the FDA for two indications for the treatment of advanced nasopharyngeal cancer.

According to the Wise Finance APP, Kangfang Biotechnology (09926.HK) opened 5% higher, as of the time of this report, it has risen 5% to 105 Hong Kong dollars, with a trading volume of 27.825 million Hong Kong dollars.